Medivation 10-Q 2016 Q2 Quarterly report

Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth inRule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350), David T. Hung, M.D., President and Chief Executive Officer of Medivation, Inc. (the “Company”), and Jennifer Jarrett, Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:

(1) The Company’s Quarterly Report onForm 10-Q for the period ended June 30, 2016, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

(2) The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, each of the undersigned has set his or her hand hereto as of the 9th day of August, 2016.

/s/ David T. Hung, M.D.	/s/ Jennifer Jarrett
Name: David T. Hung, M.D.   Title:   President and Chief Executive Officer	Name: Jennifer Jarrett Title:   Chief Financial Officer

This certification accompanies theForm 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Medivation, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of theForm 10-Q), irrespective of any general incorporation language contained in such filing.